Clinical Trial Update: A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and efficacy of HPN-100 in subjects with liver cirrhosis and episodic hepatic encephalopathy has completed, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy
• Liver Cirrhosis

Drugs mentioned

• HPN-100

Snippet

Sponsor: Amgen | Conditions: Cirrhosis, Hepatic Encephalopathy | Phase 2 | Status: COMPLETED | Results posted: 2015-09-30